Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05318521 |
| Consolidated Lead Sponsor | Overseas Pharmaceuticals |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 500 participants (ESTIMATED) |
| Registered Start Date | 2021-12-10 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Coastal Carolina Research Center | North Charleston, SC | Open Hospital Dossier -> |
| Taipei Medical University Shuang Ho Hospital | New Taipei City, Taiwan | Open Hospital Dossier -> |
| China Medical University Hospital | Taichung, Taiwan | Open Hospital Dossier -> |
| Taipei Medical University Hospital | Taipei, Taiwan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.